SANEGENE BIO

Sanegene Bio is currently operating in stealth mode.

#SimilarOrganizations #Financial #More

SANEGENE BIO

Industry:
Biopharma Health Care Medical

Founded:
2021-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Status:
Active

Total Funding:
38 M USD


Similar Organizations

impact-biomedicines-logo

Impact Biomedicines

Impact Biomedicines is pioneering the development of life-changing treatments for patients.

smartpharm-therapeutics-logo

SmartPharm Therapeutics

SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

Investors List

qiming-venture-partners_image

Qiming Venture Partners

Qiming Venture Partners investment in Series A - Sanegene Bio

More informations about "Sanegene Bio"

SanegeneBio

Sanegene Announced First-in-Human Phase I Clinical Data for C3-Targeting siRNA Drug SGB-9768 at the 8th Complement-Based Drug Development Summit Aug. 06, 2024 SanegeneBio โ€ฆSee details»

About Us - SanegeneBio

SanegeneBio is an emerging RNAi-based company developing innovative RNA interference (RNAi) therapeutics driven by the cutting-edge delivery technology.See details»

Sanegene Bio - Crunchbase Company Profile & Funding

Organization. Sanegene Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Sanegene โ€ฆSee details»

Sanegene Bio 2025 Company Profile: Valuation, โ€ฆ

Mar 12, 2022 Sanegene Bio General Information Description. Developer of RNA interference (RNAi) therapeutics designed to knock down disease-causing genes. The company's products are constructed and developed with RNA technology โ€ฆSee details»

Sanegene Bio - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โ€ฆSee details»

SanegeneBio Raised nearly $100 Million in Series A+ Financing โ€ฆ

With the excellent leadership of the team, Sanegene is expected to quickly grow into an international industry leader. K2 Venture Partners said that, it is an honor to lead the early โ€ฆSee details»

Sanegene Bio USA Inc - CEO and Investor Conference 2025

March 2-3, 2026ใƒปMiami, FL. Home; About. Event Overview; 2025 Schedule at a Glance; 2025 Event Preview WebinarSee details»

Sanegene Bio - Crunchbase

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs. New. Resources. Advanced Search. Start Free Trial . Talk With Sales ... Experience the new โ€ฆSee details»

Sanegene Bio Usa, Inc. - Drug pipelines, Patents, Clinical trials

Jan 23, 2025 Explore Sanegene Bio Usa, Inc. with its drug pipeline, therapeutic area, technology platform, 3 news, Technology Platform:siRNA, Drug:SGB-3908, DSGB-3908. ... The statistics โ€ฆSee details»

Sanegene Bio - Org Chart, Teams, Culture & Jobs - The โ€ฆ

View Sanegene Bio's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Sanegene Bio USA Inc - BIO Investor Forum 2024

Sanegene Bio USA Inc | Biotech or pharma, therapeutic R&D Address Boston Massachusetts United States Contact Exhibitor. Full Name * Email Address * Contact Message * ... More BIO โ€ฆSee details»

Sanegene Bio - Products, Competitors, Financials, Employees ...

Sanegene Bio is a biotechnology company focused on the development of RNA interference (RNAi) therapeutics within the biopharmaceutical industry. The company develops RNAi โ€ฆSee details»

SanegeneBio - Work in biotech

SanegeneBio is developing RNA interference (RNAi) therapeutics for unmet clinical needs. RNAi triggers the gene silencing to reduce the protein production of specific targets by leveraging an โ€ฆSee details»

Sanegene Bio - Updates, News, Events, Signals & Triggers

Sanegene Bio may be growing as it has entered into a strategic collaboration to develop an siRNA drug for the treatment of hypertension, indicating an expansion of its research and โ€ฆSee details»

Sanegene Bio USA Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Sanegene Bio USA Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»

Sanegene Bio Usa, Inc. (Sanegene Bio Usa, Inc.) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ๅˆฉ_ โ€ฆ

SAN FRANSCISO and SUZHOU, China, Aug. 1, 2024. Innovent Biologics, Inc. ("Innovent"), a world-class biopharmaceutical company that develops, manufactures and commercializes โ€ฆSee details»

Series A - Sanegene Bio - 2022-11-29 - Crunchbase

Nov 29, 2022 Organization Name . Sanegene Bio . Announced Date Nov 29, 2022; Funding Type Series A; Funding Stage Early Stage Venture; Lead Investors. Edit Lead Investors โ€ฆSee details»

Sanegene Bio Company Profile: Overview and Full News Analysis

Sanegene Bio has also secured significant funding, with nearly $100 million raised in Series A+ financing led by Tencent Investment and Yuanbio Venture Capital. Notably, Sanegene Bio โ€ฆSee details»

Exploring the Latest AGT siRNA Deal by Sanegene Bio (Suzhou): A โ€ฆ

Jan 13, 2024 On December 27, 2023, Innovent Biologics, Inc. and Sanegene Bio (Suzhou) Co., Ltd. jointly announced that they have entered into a strategic collaboration agreement to co โ€ฆSee details»

Sanegene Bio - Contacts, Employees, Board Members

Organization. Sanegene Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Contacts 3. โ€ฆSee details»

linkstock.net © 2022. All rights reserved